NCT00377546View on ClinicalTrials.gov

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Vitrectomy

Interventions

DRUG

Nepafenac

DRUG

Ketorolac LS, Bromfenac

Trial Locations (1)

02114

Ophthalmic Consultants of Boston, Boston

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00377546 - Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% | Biotech Hunter | Biotech Hunter